Apex Biotechnology Corp. (TPE:1733)

Apex Biotechnology Revenue

Apex Biotechnology had revenue of 437.21M TWD in the quarter ending September 30, 2025, a decrease of -14.20%. This brings the company's revenue in the last twelve months to 1.96B, up 8.38% year-over-year. In the year 2024, Apex Biotechnology had annual revenue of 1.85B with 10.48% growth.

• Revenue (ttm): 1.96B
• Revenue Growth: +8.38%
• P/S Ratio: 1.56
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 3.05B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.85B	175.67M	10.48%
Dec 31, 2023	1.68B	-567.64M	-25.29%
Dec 31, 2022	2.24B	112.52M	5.28%
Dec 31, 2021	2.13B	126.32M	6.30%
Dec 31, 2020	2.01B	-193.53M	-8.80%